Trial intelligence / Profile preview

Preoperative oral midazolam sedation for pediatric outpatient dental surgery

ChiCTR2200066686Phase 4Not yet recruiting

Sponsor
Peking University School and Hospital of Stomatology
Start
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of midazolam in separation anxiety disorder (SAD) (2 arms), sponsored by Peking University School and Hospital of Stomatology. Primary endpoint: Separation anxiety score when children leave their parents. Planned start Dec 2022; status: not yet recruiting.

02

Drugs

midazolam
03

Conditions

separation anxiety disorder (SAD)

Beyond the preview

Go deeper on ChiCTR2200066686.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200066686.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call